6-(2,4-dimethoxypyrimidin-5-yl)-8-[(1S,2S)-2-[2-(trifluoromethyl)pyrimidin-4-yl]cyclopropyl]imidazo[1,2-b]pyridazine

C20H16F3N7O2 — CID 157034725

IUPAC6-(2,4-dimethoxypyrimidin-5-yl)-8-[(1S,2S)-2-[2-(trifluoromethyl)pyrimidin-4-yl]cyclopropyl]imidazo[1,2-b]pyridazine
SMILESCOc1ncc(-c2cc([C@H]3C[C@@H]3c3ccnc(C(F)(F)F)n3)c3nccn3n2)c(OC)n1
InChIInChI=1S/C20H16F3N7O2/c1-31-17-13(9-26-19(28-17)32-2)15-8-12(16-24-5-6-30(16)29-15)10-7-11(10)14-3-4-25-18(27-14)20(21,22)23/h3-6,8-11H,7H2,1-2H3/t10-,11-/m0/s1
InChIKeyDQEJVWUTERMKQS-QWRGUYRKSA-N
MW443.39 g/mol
LogP3.28
Rot. Bonds5

About 6-(2,4-dimethoxypyrimidin-5-yl)-8-[(1S,2S)-2-[2-(trifluoromethyl)pyrimidin-4-yl]cyclopropyl]imidazo[1,2-b]pyridazine

6-(2,4-dimethoxypyrimidin-5-yl)-8-[(1S,2S)-2-[2-(trifluoromethyl)pyrimidin-4-yl]cyclopropyl]imidazo[1,2-b]pyridazine (PubChem CID 157034725) has the molecular formula C20H16F3N7O2 and a molecular weight of 443.39 g/mol. Its IUPAC name is 6-(2,4-dimethoxypyrimidin-5-yl)-8-[(1S,2S)-2-[2-(trifluoromethyl)pyrimidin-4-yl]cyclopropyl]imidazo[1,2-b]pyridazine.

Molecular Properties

Compound Name6-(2,4-dimethoxypyrimidin-5-yl)-8-[(1S,2S)-2-[2-(trifluoromethyl)pyrimidin-4-yl]cyclopropyl]imidazo[1,2-b]pyridazine
PubChem CID157034725
Molecular FormulaC20H16F3N7O2
Molecular Weight443.39 g/mol
Exact Mass443.13
IUPAC Name6-(2,4-dimethoxypyrimidin-5-yl)-8-[(1S,2S)-2-[2-(trifluoromethyl)pyrimidin-4-yl]cyclopropyl]imidazo[1,2-b]pyridazine
SMILESCOc1ncc(-c2cc([C@H]3C[C@@H]3c3ccnc(C(F)(F)F)n3)c3nccn3n2)c(OC)n1
InChIInChI=1S/C20H16F3N7O2/c1-31-17-13(9-26-19(28-17)32-2)15-8-12(16-24-5-6-30(16)29-15)10-7-11(10)14-3-4-25-18(27-14)20(21,22)23/h3-6,8-11H,7H2,1-2H3/t10-,11-/m0/s1
InChIKeyDQEJVWUTERMKQS-QWRGUYRKSA-N
XLogP3.28
TPSA100.21 Ų
H-Bond Donors
H-Bond Acceptors9
Rotatable Bonds5
Heavy Atoms32
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500443.39
LogP ≤ 53.28
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 109

Analyze 6-(2,4-dimethoxypyrimidin-5-yl)-8-[(1S,2S)-2-[2-(trifluoromethyl)pyrimidin-4-yl]cyclopropyl]imidazo[1,2-b]pyridazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 6-(2,4-dimethoxypyrimidin-5-yl)-8-[(1S,2S)-2-[2-(trifluoromethyl)pyrimidin-4-yl]cyclopropyl]imidazo[1,2-b]pyridazine?
The IUPAC name of 6-(2,4-dimethoxypyrimidin-5-yl)-8-[(1S,2S)-2-[2-(trifluoromethyl)pyrimidin-4-yl]cyclopropyl]imidazo[1,2-b]pyridazine (CID 157034725) is 6-(2,4-dimethoxypyrimidin-5-yl)-8-[(1S,2S)-2-[2-(trifluoromethyl)pyrimidin-4-yl]cyclopropyl]imidazo[1,2-b]pyridazine.
What is the SMILES notation for 6-(2,4-dimethoxypyrimidin-5-yl)-8-[(1S,2S)-2-[2-(trifluoromethyl)pyrimidin-4-yl]cyclopropyl]imidazo[1,2-b]pyridazine?
The canonical SMILES for 6-(2,4-dimethoxypyrimidin-5-yl)-8-[(1S,2S)-2-[2-(trifluoromethyl)pyrimidin-4-yl]cyclopropyl]imidazo[1,2-b]pyridazine is COc1ncc(-c2cc([C@H]3C[C@@H]3c3ccnc(C(F)(F)F)n3)c3nccn3n2)c(OC)n1.
What is the InChIKey of 6-(2,4-dimethoxypyrimidin-5-yl)-8-[(1S,2S)-2-[2-(trifluoromethyl)pyrimidin-4-yl]cyclopropyl]imidazo[1,2-b]pyridazine?
The InChIKey is DQEJVWUTERMKQS-QWRGUYRKSA-N. The full InChI is InChI=1S/C20H16F3N7O2/c1-31-17-13(9-26-19(28-17)32-2)15-8-12(16-24-5-6-30(16)29-15)10-7-11(10)14-3-4-25-18(27-14)20(21,22)23/h3-6,8-11H,7H2,1-2H3/t10-,11-/m0/s1.
What are the key properties of 6-(2,4-dimethoxypyrimidin-5-yl)-8-[(1S,2S)-2-[2-(trifluoromethyl)pyrimidin-4-yl]cyclopropyl]imidazo[1,2-b]pyridazine?
6-(2,4-dimethoxypyrimidin-5-yl)-8-[(1S,2S)-2-[2-(trifluoromethyl)pyrimidin-4-yl]cyclopropyl]imidazo[1,2-b]pyridazine has a molecular weight of 443.39 g/mol, XLogP of 3.28, 5 rotatable bonds, 0 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 6-(2,4-dimethoxypyrimidin-5-yl)-8-[(1S,2S)-2-[2-(trifluoromethyl)pyrimidin-4-yl]cyclopropyl]imidazo[1,2-b]pyridazine is sourced from PubChem (CID 157034725), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).